# Monopar Therapeutics: Form DEF 14A, filed Jul 22, 2024

- Company: [Monopar Therapeutics](/companies/mnpr.md) (CIK 1645469)
- Form: DEF 14A
- Filed: 2024-07-22
- Accepted by EDGAR: Jul 22, 2024, 07:00 ET
- Period: 2024-08-05
- Accession: 0001437749-24-023123
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1645469/000143774924023123/mnpr20240714_def14a.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1645469/000143774924023123/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1645469/000143774924023123/mnpr20240714_def14a.htm

Filed Jul 22, 2024.
Source: SEC EDGAR, the filing index for accession 0001437749-24-023123. Last ingested by Listed: Nov 12, 2026, 18:09 ET. No prices; not investment advice.
